Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Gene Therapy to Target CD19 for Oncology by Chongqing Precision Biotech for Primary Mediastinal B-Cell Lymphoma: Likelihood of Approval
Gene Therapy to Target CD19 for Oncology is under clinical development by Chongqing Precision Biotech and currently in Phase I...
Gene Therapy to Target CD19 for Oncology by Chongqing Precision Biotech for Follicular Lymphoma: Likelihood of Approval
Gene Therapy to Target CD19 for Oncology is under clinical development by Chongqing Precision Biotech and currently in Phase I...
Gene Therapy to Target CD19 for Oncology by Chongqing Precision Biotech for Mantle Cell Lymphoma: Likelihood of Approval
Gene Therapy to Target CD19 for Oncology is under clinical development by Chongqing Precision Biotech and currently in Phase I...
Gene Therapy to Target CD19 for Oncology by Chongqing Precision Biotech for Diffuse Large B-Cell Lymphoma: Likelihood of Approval
Gene Therapy to Target CD19 for Oncology is under clinical development by Chongqing Precision Biotech and currently in Phase I...
Gene Therapy to Target CD19 for Oncology by Chongqing Precision Biotech for Chronic Lymphocytic Leukemia (CLL): Likelihood of Approval
Gene Therapy to Target CD19 for Oncology is under clinical development by Chongqing Precision Biotech and currently in Phase I...